Cytogen Inc (217330) — Financial Flexibility Index
Cytogen Inc (217330) has a Financial Flexibility Index of -0.08x as of December 2025. Free cash flow of ₩-2.08 Billion (operating CF ₩-2.13 Billion minus capex ₩49.52 Million) represents 0% of total liabilities (₩26.25 Billion). Check asset allocation strategy of Cytogen Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytogen Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Cytogen Inc across 12 annual periods. See working capital position of Cytogen Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cytogen Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Cytogen Inc. For the full company profile including market capitalisation, see Cytogen Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | ₩-4.92 Billion | ₩-6.95 Billion | ₩26.25 Billion | ▲ +46.8% |
| 2024 | -0.35x | ₩-8.41 Billion | ₩-9.53 Billion | ₩23.89 Billion | ▼ -49.3% |
| 2023 | -0.24x | ₩-4.97 Billion | ₩-7.59 Billion | ₩21.09 Billion | ▼ -48.8% |
| 2022 | -0.16x | ₩-5.63 Billion | ₩-6.38 Billion | ₩35.56 Billion | ▼ -59.3% |
| 2021 | -0.10x | ₩-3.23 Billion | ₩-5.23 Billion | ₩32.52 Billion | ▲ +76.4% |
| 2020 | -0.42x | ₩-4.20 Billion | ₩-4.47 Billion | ₩9.97 Billion | ▲ +73.1% |
| 2019 | -1.56x | ₩-2.81 Billion | ₩-3.37 Billion | ₩1.80 Billion | ▲ +23.7% |
| 2018 | -2.05x | ₩-1.46 Billion | ₩-2.77 Billion | ₩711.51 Million | ▼ -4.1% |
| 2017 | -1.97x | ₩-1.86 Billion | ₩-2.18 Billion | ₩947.50 Million | ▼ -347.6% |
| 2016 | -0.44x | ₩-2.02 Billion | ₩-2.36 Billion | ₩4.59 Billion | ▲ +58.1% |
| 2015 | -1.05x | ₩-1.67 Billion | ₩-2.03 Billion | ₩1.60 Billion | ▼ -250.0% |
| 2014 | -0.30x | ₩-470.57 Million | ₩-1.03 Billion | ₩1.57 Billion | — |